CoChat

Serum androgen profiles in women with premature ovarian insufficiency: a systematic review and meta-analysis

Open access
Soman, Midhun, Huang, Li-Cong, Cai, Wen-Hui, Xu, Jun-Bi, Chen, Jun-Yao, He, Ren-Ke, Ruan, Heng-Chao, Xu, Xiang-Rong, Qian, Zhi-Da, Zhu, Xiao-Ming · 2019 · Menopause

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Abstract

Objective: This meta-analysis aims to investigate serum androgen profiles (testosterone, dehydroepiandrosterone sulfate, androstenedione, and sex hormone-binding globulin) in women with premature ovarian failure and to establish if there is evidence of diminished androgen levels in these women. Methods: Various Internet sources of PubMed, Cochrane library, and Medline were searched systematically until February, 2018. Out of a pool of 2,461 studies, after applying the inclusion/exclusion criterion, 14, 8, 10, and 9 studies were chosen for testosterone, dehydroepiandrosterone sulfate, androstenedione, and sex hormone-binding globulin, respectively, for this meta-analysis. The effect measure was the standardized mean difference with 95% confidence interval (95% CI) in a random-effects model. Results: The testosterone concentrations in premature ovarian insufficiency were compared with fertile controls: stamdard mean difference (IV, random, 95% CI) −0.73 [−0.99, −0.46], P value < 0.05. The dehydroepiandrosterone sulfate concentrations in premature ovarian insufficiency compared to fertile controls: standard mean difference (IV, random, 95% CI) −0.65 [−0.92, −0.37], P value < 0.05. Androstenedione in premature ovarian insufficiency were compared with fertile controls: standard mean difference (IV, random, 95% CI) −1.09 [−1.71, −0.48], P value < 0.05. Sex hormone-binding globulin levels did not show statistical significance. The dehydroepiandrosterone sulfate levels were reduced in premature ovarian insufficiency cases, but still showed a higher level than in postmenopausal women. Conclusions: Women with premature ovarian insufficiency are at risk for decreased concentrations of testosterone, dehydroepiandrosterone sulfate, and androstenedione. Dehydroepiandrosterone sulfate levels were more reduced in postmenopausal controls when compared with premature ovarian insufficiency cases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/gme.0000000000001161

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIG. 1 Search strategy, PRISMA flow chart for meta-analysis on total androgen concentrations.
FIG. 1 Search strategy, PRISMA flow chart for meta-analysis on total androgen concentrations.CC BY-NC-ND · PubMed Central
FIG. 2 Forest plot for meta-analysis of 14 comparative studies on total testosterone concentrations in women with POI/POF compared with fertile controls. Squares represent effect of each study, and the diamond represents the overall effect of the study at 95% confidence intervals. The values to the left of the solid line indicate SMD less than 1, decreased concentrations in POI/POF group. The values to the right of the solid line indicate SMD greater than 1, increased concentrations in POF/POI when compared to the control group. POF, primary ovarian failure; POI, premature ovarian insufficiency; SMD, standardized mean difference.
FIG. 2 Forest plot for meta-analysis of 14 comparative studies on total testosterone concentrations in women with POI/POF compared with fertile controls. Squares represent effect of each study, and the diamond represents the overall effect of the study at 95% confidence intervals. The values to the left of the solid line indicate SMD less than 1, decreased concentrations in POI/POF group. The values to the right of the solid line indicate SMD greater than 1, increased concentrations in POF/POI when compared to the control group. POF, primary ovarian failure; POI, premature ovarian insufficiency; SMD, standardized mean difference.CC BY-NC-ND · PubMed Central
FIG. 3 Sensitivity analysis for total testosterone concentrations in women with POI/POF compared with fertile controls. Four studies (n = 615) that scored >6 on the Newcastle-Ottawa Scale, considered as the best quality studies, were chosen out of the 14 studies. POF, primary ovarian failure; POI, premature ovarian insufficiency.
FIG. 3 Sensitivity analysis for total testosterone concentrations in women with POI/POF compared with fertile controls. Four studies (n = 615) that scored >6 on the Newcastle-Ottawa Scale, considered as the best quality studies, were chosen out of the 14 studies. POF, primary ovarian failure; POI, premature ovarian insufficiency.CC BY-NC-ND · PubMed Central
FIG. 4 Forest plot for meta-analysis of eight comparative studies on DHEA-S concentrations in women with POI/POF compared with fertile controls. Squares represent effect of each study, and the diamond represents the overall effect of the study at 95% confidence intervals. The values to the left of the solid line indicate SMD less than 1, decreased concentrations in POI/POF group. The values to the right of the solid line indicate SMD greater than 1, increased concentrations in POF/POI compared to the control group. DHEA-S, dehydroepiandrosterone sulfate; POF, primary ovarian failure; POI, premature ovarian insufficiency; SMD, standardized mean difference.
FIG. 4 Forest plot for meta-analysis of eight comparative studies on DHEA-S concentrations in women with POI/POF compared with fertile controls. Squares represent effect of each study, and the diamond represents the overall effect of the study at 95% confidence intervals. The values to the left of the solid line indicate SMD less than 1, decreased concentrations in POI/POF group. The values to the right of the solid line indicate SMD greater than 1, increased concentrations in POF/POI compared to the control group. DHEA-S, dehydroepiandrosterone sulfate; POF, primary ovarian failure; POI, premature ovarian insufficiency; SMD, standardized mean difference.CC BY-NC-ND · PubMed Central
FIG. 5 Subgroup analysis for DHEA-S concentrations in women with POI/POF compared with postmenopausal controls (n = 465), indicating that the DHEA-S levels are much reduced in POI/POF controls, but still show a higher concentration than DHEA-S in postmenopausal women. DHEA-S, dehydroepiandrosterone sulfate; POF, primary ovarian failure; POI, premature ovarian insufficiency.
FIG. 5 Subgroup analysis for DHEA-S concentrations in women with POI/POF compared with postmenopausal controls (n = 465), indicating that the DHEA-S levels are much reduced in POI/POF controls, but still show a higher concentration than DHEA-S in postmenopausal women. DHEA-S, dehydroepiandrosterone sulfate; POF, primary ovarian failure; POI, premature ovarian insufficiency.CC BY-NC-ND · PubMed Central
FIG. 6 Sensitivity analysis for DHEA-S concentrations in women with POI/POF compared with fertile controls. Three studies (n = 210) that scored >6 on the Newcastle-Ottawa Scale, considered as the best quality studies, were chosen out of the eight studies. DHEA-S, dehydroepiandrosterone sulfate; POF, primary ovarian failure; POI, premature ovarian insufficiency.
FIG. 6 Sensitivity analysis for DHEA-S concentrations in women with POI/POF compared with fertile controls. Three studies (n = 210) that scored >6 on the Newcastle-Ottawa Scale, considered as the best quality studies, were chosen out of the eight studies. DHEA-S, dehydroepiandrosterone sulfate; POF, primary ovarian failure; POI, premature ovarian insufficiency.CC BY-NC-ND · PubMed Central
FIG. 7 Forest plot for meta-analysis of 10 comparative studies androstenedione concentrations in women with POI/POF compared with fertile controls. The values to the left of the solid line indicate SMD less than 1, decreased concentrations in POI/POF group. The values to the right of the solid line indicate SMD greater than 1, increased concentrations in POF/POI when compared to the control group. POF, primary ovarian failure; POI, premature ovarian insufficiency; SMD, standardized mean difference.
FIG. 7 Forest plot for meta-analysis of 10 comparative studies androstenedione concentrations in women with POI/POF compared with fertile controls. The values to the left of the solid line indicate SMD less than 1, decreased concentrations in POI/POF group. The values to the right of the solid line indicate SMD greater than 1, increased concentrations in POF/POI when compared to the control group. POF, primary ovarian failure; POI, premature ovarian insufficiency; SMD, standardized mean difference.CC BY-NC-ND · PubMed Central
FIG. 8 Sensitivity analysis for androstenedione concentrations in women with POI/POF compared with fertile controls. Three studies (n = 463) that scored >6 on the Newcastle-Ottawa Scale, considered as the best quality studies, were chosen out of the 10 studies. POF, primary ovarian failure; POI, premature ovarian insufficiency.
FIG. 8 Sensitivity analysis for androstenedione concentrations in women with POI/POF compared with fertile controls. Three studies (n = 463) that scored >6 on the Newcastle-Ottawa Scale, considered as the best quality studies, were chosen out of the 10 studies. POF, primary ovarian failure; POI, premature ovarian insufficiency.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 51 references

Cited by

See all 63

Metadata

Authors
Soman, M., Huang, L.-C., Cai, W.-H., Xu, J.-B., Chen, J.-Y., He, R.-K., Ruan, H.-C., Xu, X.-R., Qian, Z.-D., & Zhu, X.-M.
Affiliations
  • Women's Hospital, School of Medicine, Zhejiang University (CN)
  • Department of Obstetrics & Gynecology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, P.R. China
Corresponding author
Xu, Jun-Bi
Venue
Menopause
Published
2019-01
Volume
26
Issue
1
Pages
78-93
ISSN
  • 1072-3714 (ISSN-L)
  • 1530-0374
OpenAlex
W2824376129
Cited by
63
References
51
Citations by year
2026: 1 · 2025: 6 · 2024: 5 · 2023: 8 · 2022: 21 · 2021: 12 · 2020: 7 · 2019: 3
FWCI
0.83
Type
journal article
Language
en
Open access
Locations
  • Menopause The Journal of The North American Menopause Society (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords
premature ovarian insufficiency, serum androgens, testosterone, dehydroepiandrosterone sulfate, androstenedione, sex hormone-binding globulin, postmenopausal women, androgen deficiency
MeSH terms
Adult, Androgens, Androstenedione, Female, Fertility, Humans, Menopause, Premature, Middle Aged, Sex Hormone-Binding Globulin, Testosterone, Women's Health, Primary Ovarian Insufficiency, Postmenopause, Dehydroepiandrosterone Sulfate, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Serum androgen profiles in women with premature ovarian insufficiency: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1097/gme.0000000000001161
The paper
Soman, M., Huang, L.-C., Cai, W.-H., Xu, J.-B., Chen, J.-Y., He, R.-K., Ruan, H.-C., Xu, X.-R., Qian, Z.-D., & Zhu, X.-M. (2019). Serum androgen profiles in women with premature ovarian insufficiency: a systematic review and meta-analysis. Menopause. https://doi.org/10.1097/gme.0000000000001161

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.